The O’Neill Institute Infectious Diseases and the Law course will be co-directed by Professors Lawrence Gostin and Jeffrey Crowley. The Summer Program will bring together leading practitioners, policymakers, advocates, and academics in global health to explore the role and implications of law in the global response to infectious diseases. Interactive lectures, panels, and case studies will examine legal powers, duties, and constraints relevant to infectious diseases.
Lawrence O. Gostin an internationally acclaimed scholar, is University Professor, Georgetown University’s highest academic rank conferred by the University President. Prof. Gostin directs the O’Neill Institute for National and Global Health Law and was the Founding O’Neill Chair in Global Health Law. He served as Associate Dean for Research at Georgetown Law from 2004 to 2008. He is Professor of Medicine at Georgetown University, and Visiting Professor, Oxford University. Professor Gostin is also Director, of the World Health Organization Collaborating Center on Public Health Law and Human Rights. He has published extensively on domestic legal and regulatory mechanisms to address NCDs, as well as model public health laws and governance issues in global health.
Jeffrey S. Crowley is the Program Director of the National HIV/AIDS Initiative at the O’Neill Institute for National and Global Health Law and Distinguished Scholar. Mr. Crowley is a widely recognized expert on HIV/AIDS and disability policy. From February 2009 through December 2011, he served as the Director of the White House Office of National AIDS Policy and Senior Advisor on Disability Policy for President Barack Obama. In this capacity, he led the development of our country’s first domestic National HIV/AIDS Strategy for the United States, a five-year plan for aligning the efforts of all stakeholders to reduce the number of new HIV infections, increase access to care, and reduce HIV-related health disparities. The Strategy continues to guide the Administration’s efforts in this area. He also coordinated disability policy development for the Domestic Policy Council and worked on the policy team that spearheaded the development and implementation of the Affordable Care Act.
Roberta Andraghetti, Pan American Health Organization (PAHO)
Seth Berkley, MD (attending via video conference) Dr. Seth Berkley joined Gavi, the Vaccine Alliance as CEO in August 2011, as it launched its five-year strategy to immunise a quarter of a billion children in the developing world with life-saving vaccines by 2015. He has overseen a dramatic expansion in the number of vaccines Gavi provides as well as an increase in vaccines coverage. Prior to joining Gavi, Dr. Berkley was the founder, president and CEO for 15 years of the International AIDS Vaccine Initiative (IAVI), the first vaccine product development public-private sector partnership. Under his leadership, IAVI created a virtual vaccine product development effort involving industry, academia, and developing country scientists – developing and testing vaccines around the world. He also oversaw a global advocacy programme that assured that HIV vaccines received prominent attention in the media and in forums such as the G-8, EU and the UN. Prior to founding IAVI, Dr. Berkley served as an officer in the Health Sciences Division at The Rockefeller Foundation. He has also worked for the Center for Infectious Diseases of the U.S. Centers for Disease Control and Prevention (CDC), the Massachusetts Department of Public Health and for the Task Force for Child Survival at the Carter Center where he served as an epidemiologist at the Ministry of Health in Uganda. He has consulted or worked in more than 50 countries in Asia, Africa and Latin America. Dr. Berkley sits on a number of international steering committees and corporate and not-for-profit boards, including those of Gilead Sciences, the New York Academy of Sciences and the Acumen Fund. He has been featured on the cover of Newsweek, recognised by TIME magazine as one of the “100 Most Influential People in the World” and by Wired Magazine as among “The Wired 25-a salute to dreamers, inventors, mavericks and leaders.” Dr. Berkley received his undergraduate and medical degrees from Brown University and trained in internal medicine at Harvard University. In 2013, Dr. Berkley was awarded an Honorary Doctorate by Nelson Mandela Metropolitan University in Port Elizabeth, South Africa, for services to global public health and advancing the right to healthcare for all.
Gail Bolan, MD was appointed Director of CDC’s Division of Sexually Transmitted Disease Prevention (DSTDP) at the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention in December 2010. She began her public health career in 1982 as an Epidemic Intelligence Service (EIS) officer in the Respiratory and Special Pathogens Branch at CDC. She gained international experience with a three month meningitis surveillance project in Burkina Faso, Africa. Following EIS, she completed an infectious disease fellowship that included bench research on the characterization of a Neisseria gonorrhoeae iron-regulating protein that was thought to be a potential vaccine antigen candidate. In 1987, she began a life-time career in the field of STD prevention and control as Director of the STD Prevention and Control Program at the San Francisco Department of Public Health jointly with an academic appointment in the Department of Medicine at University of California San Francisco Medical School. In 1997, she became the Chief of the STD Control Branch at the California Department of Public Health as well as the Director of the California STD/HIV Prevention Training Center. In these positions, she consistently demonstrated a strong and enthusiastic commitment to the field of STD prevention.
Daniel Bruner, JD, MPP is the Senior Director of Policy at Whitman-Walker Health. His expertise is in discrimination in employment and health care; access to health care; medical privacy; and public health law and policy. He served as Whitman-Walker’s Director of Legal Services for 10 years. Prior to joining Whitman-Walker in 1995, Bruner was a partner at the Washington, DC law firm of Spiegel & McDiarmid, during which time he did pro bono work with Whitman-Walker, the Pennsylvania AIDS Law Project, and Lambda Legal. Between 2000 and 2005, he was an adjunct faculty member at American University’s Washington College of Law, where he taught seminars on AIDS and the Law and courses on Public Health Law. Bruner has received awards from the LGBT Bar Association of DC and the Washington Council of Lawyers, and is a past Co-Chair of the DC Consortium of Legal Services Providers. He received his law degree (magna cum laude) and master’s degree in public policy from the University of Michigan. He is the author of the “Forward” in David W. Webber et al., AIDS and the Law (4th ed. 2007), and High-Risk Sexual Behavior By Persons Living With HIV/AIDS, and Failure to Disclose HIV Infection to Sex Partners: How Do We Respond? Journal of AIDS and Public Policy 19, no. 1/2 (2004), and has given many presentations on HIV and LGBT law.
Martha Cameron, MPH is the Director of Policy and Advocacy Programs for Women’s Collective. She is originally from Zambia, Africa where she worked as the Director of an International faith based non-profit called Every Orphan’s Hope (EOH) Inc. running HIV programs for orphans and widows. In the United States she has been actively involved in various HIV Policy and Advocacy activities including serving on the Metropolitan Washington Regional Ryan White Planning Council, and as a team leader in this DC EMA Ryan White Cross-Part Quality Collaborative. She has a Masters in Public health and background in health policy, project planning implementation, evaluation and quality. She is passionatie about HIV prevention, treatment, trauma informed care, and sexual and reporductive health.
Robert Carr, MD, MPH serves as Director of the Executive Master of Science in Health Systems Administration (EMHSA) Program at Georgetown University, where he teaches on organizational leadership, human capital management, and other topics. Dr. Carr has an extensive background in health outcomes, human performance, systems & culture and change management enhancing human health and performance and ultimately business improvement. He is President-elect of the American College of Preventive Medicine, the specialty society of Preventive Medicine and physicians dedicated to evidence-based health promotion, disease prevention, and systems-based approaches to improving health and health care. He was most recently the Senior Vice President & Corporate Medical Director at GlaxoSmithKline (retired) where he provided strategic direction and leadership in all areas of employee health and performance, heading a global professional team covering 124 international sites with a workforce of over 100,000 employees who generated annual revenues of almost $40 billion in 2014.
Martin Cetron, MD is director of the Division of Global Migration and Quarantine (DGMQ) at the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). He previously served as director of DGMQ when it was within the National Center for Preparedness, Detection, and Control of Infectious Diseases. DGMQ’s mission is to prevent the introduction and spread of infectious diseases into the United States and to prevent morbidity and mortality among immigrants, refugees, migrant workers, and international travelers. Dr. Cetron’s primary research interest is international health and global migration with a focus on emerging infections, tropical diseases, and vaccine-preventable diseases in mobile populations. Since coming to CDC in 1992, Dr. Cetron he has led a number of domestic and international outbreak investigations, conducted epidemiologic research, and been involved in domestic and international emergency responses to provide medical screening and disease prevention programs to refugees prior to U.S. resettlement. He played a leadership role in CDC responses to intentional and naturally acquired emerging infectious disease outbreaks, including the anthrax bioterrorism incident, the global SARS epidemic, the U.S. monkeypox outbreak, and the H1N1 pandemic. Dr. Cetron also is part of CDC’s Pandemic Influenza Planning and Preparedness Team. He holds faculty appointments in the Division of Infectious Diseases at the Emory University School of Medicine and the Department of Epidemiology at Rollins School of Public Health. Dr. Cetron received his bachelor of arts degree from Dartmouth College in 1981 and his MD from Tufts University in 1985. He trained in internal medicine at the University of Virginia and infectious diseases at the University of Washington before becoming a commissioned officer in the U.S. Public Health Service in 1992.
Richard E. Chaisson, MD is Professor of Medicine, Epidemiology and International Health at the Johns Hopkins University in Baltimore. He received his BS and MD degrees from the University of Massachusetts, and was an intern, resident and fellow at the University of California, San Francisco, where he was also Assistant Professor of Medicine. From 1988-1998 he was director of the Johns Hopkins AIDS Service, and he co-founded the Johns Hopkins HIV Clinic cohort, an observational study that has been the source of more than 130 scientific publications on the outcomes of HIV disease and its treatment. Dr. Chaisson is currently Director of the Johns Hopkins Center for Tuberculosis Research, a multidisciplinary center with more than $60 million in grants for the study of TB from bench to bedside. Dr. Chaisson’s research interests focus on tuberculosis and HIV infection, including global epidemiology, clinical trials, diagnostics and public health interventions. He is currently principal investigator of 11 research grants, and is director of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), an international research consortium funded by the Bill and Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related TB. He has published over 300 scientific papers and book chapters.
Sugy Choi, MS Seoul National University College of Medicine
Brian Citro, JD is a Clinical Lecturer in Law and the Acting Director of the International Human Rights Clinic at the University of Chicago Law School. He is also the Director of “Developing a Rights-Based Approach to TB,” a project funded by the University of Chicago Center in Delhi and the Pozen Family Center for Human Rights. He is a 2010 graduate of the University of Chicago Law School, where he was co-founder and Chair of the Human Rights Law Society. Prior to joining the clinical faculty, he worked for two years in New Delhi, India, as a Senior Research Officer to the UN Special Rapporteur on the Right to Health and Project Manager of the Global Health and Human Rights Database for the Lawyers Collective, HIV/AIDS Unit. He also worked on the implementation of the Global Commission on HIV and the Law as a Legal Consultant to the UN Development Program office of HIV, Health and Development. He has traveled extensively through his work with the UN Special Rapporteur and conducted UN country missions in Viet Nam, Azerbaijan, and Tajikistan, as well as regional UN consultations in Hungary, Russia, and South Africa. He has published articles on issues related to the international right to health, access to medicines, and the human rights responsibilities of pharmaceutical companies, and he has researched and drafted UN reports submitted to the General Assembly and Human Rights Council.
Lauren Dunning, JD, MPH is the Senior Policy and Planning Officer at the Los Angeles County Department of Public Health (LAC DPH), Division of Communicable Disease Control and Prevention. She graduated from Georgetown University Law Center and Johns Hopkins Bloomberg School of Public Health, receiving a joint JD/MPH. Lauren’s work has focused on developing policy strategies for preventing communicable and chronic disease within Los Angeles County, as well as legal tools to prevent the spread of infectious diseases.
Margareta Harrit, The World Bank Group
Anthony S. Fauci, MD was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted diseases, influenza, tuberculosis, malaria, and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma, and allergies. The NIAID budget for fiscal year 2013 was approximately $4.5 billion. Dr. Fauci serves as one of the key advisors to the White House and U.S. Department of Health and Human Services on global AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza.
David Fidler is the James Louis Calamaras Professor of Law at the Indiana University Maurer School of Law and is one of the world’s leading experts on international law and global health. His books in this area include Biosecurity in the Global Age: Biological Weapons, Public Health, and the Rule of Law (Stanford University Press, 2008) (with Lawrence O. Gostin), SARS, Governance, and the Globalization of Disease (Palgrave Macmillan, 2004), International Law and Public Health: Materials on and Analysis of Global Health Jurisprudence (Transnational Publishers, 2000), and International Law and Infectious Diseases (Clarendon Press, 1999). He has published over 100 articles and chapters on global health topics in legal, public health, medical, and political science journals and books. In addition to his teaching and scholarly activities, Professor Fidler has served as an international legal consultant to the World Health Organization and the U.S. Centers for Disease Control and Prevention. He has twice been appointed by the Director-General of the World Health Organization as a member of the IHR Roster of Experts, the members of which advise the Director-General on matters relating to the International Health Regulations (2005). He is an Associate Fellow with the Centre on Global Health Security at the Royal Institute of International Affairs (Chatham House).
Camilla Graham, MD, MPH is a Co-Director of the Viral Hepatitis Center in the Division of Infectious Diseases at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School. Her main focus of clinical care and research is in HIV and hepatitis B and C, including mono- and co-infections, and using systems support to improve testing and linkage to care. She has helped implement electronic medical record prompts for HCV birth cohort-based testing at BIDMC and nationally and helps run an HCV ECHO/telemedicine program for primary care providers in community health centers in Massachusetts.
Robert Guidos, JD is Senior Advisor to the Director at the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER). Prior to joining FDA, Mr. Guidos served as Vice President of Public Policy and Government Relations at the Infectious Diseases Society of America (IDSA), where he represented IDSA’s 10,000 infectious diseases physician and scientist members. His team activated advocacy campaigns to carry IDSA’s messages to the public as well as to policymakers in the U.S. Congress, Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health, etc. Prior to joining IDSA, Mr. Guidos worked in the HHS Secretary’s Office of Legislation; FDA’s Commissioner’s Office of Legislation and Center for Veterinary Medicine; and as a Brookings Institution fellow in the offices of Senators Richard Durbin (D-IL) and Richard Lugar (R-IN). He earned his J.D. from the University of Pittsburgh School of Law and B.S. in chemistry from Gannon University. He served as a U.S. Peace Corp volunteer in Kampala, Uganda in 1992.
Sam Halabi, JD, M.Phil. is an O’Neill Institute Scholar and an Associate Professor at the University of Tulsa College of Law. Between 2008 and 2010, he served as a Fellow at O’Neill and an Adjunct Professor of Law at Georgetown University Law Center. In 2008, he assisted the Presidential Health Care Policy Working Group on approaches to international food and drug inspections. In 2010, Professor Halabi addressed a special committee of the United Nations on the relationship between decentralized health care systems and social inclusion as well as the U.N. Committee on the Elimination of All Forms of Discrimination Against Women on Egypt’s compliance with the World Health Organization’s Framework Convention on Tobacco Control. His recent policy work focuses on identifying and minimizing legal barriers to global vaccine availability. He is a member of the Editorial Board of the Food and Drug Law Journal as well as a member of the American Society of Law, Medicine and Ethics. His work has been published or is forthcoming in the Harvard International Law Journal, the Journal of Law, Medicine, and Ethics, the Michigan Journal of International Law, and the Northwestern Journal of International Law and Business, among others.
Gail Hansen, MPH serves as a senior officer for Pew’s antibiotic resistance project, for which she works to phase out overuse of antibiotics in food production. Before joining Pew, Dr. Hansen served as the state epidemiologist and state public health veterinarian for the Kansas Department of Health and Environment where most of her work centered on infectious diseases and public health policy. While there, she led a team of epidemiologists that investigated outbreaks and sporadic cases of infectious disease, evaluated public health prevention measures, and developed disease tracking systems for the state. She has served on or chaired numerous state and federal infectious disease committees, as a scientific advisor for several national and international conferences, and is an adjunct faculty member at the Kansas State University College of Veterinary Medicine. She has authored several peer-reviewed publications on various infectious diseases and public health topics and has provided practical training in applied epidemiology to public health scholars.
Nathaniel Heller, MSFS is a Managing Director at the Results for Development Institute (R4D) and leads R4D’s Governance Program, which works to harness citizen-centric transparency and accountability efforts as drivers of development outcomes. Prior to joining R4D, Nathaniel co-founded and led Global Integrity, a non-profit organization that promotes government transparency and accountability worldwide. During that time, Nathaniel conceptualized and established the OpenGov Hub, the world’s first open government-themed co-working community with locations in Washington, DC and Kathmandu, Nepal. He also created an emerging markets research company servicing consulting firms and hedge funds, now Foglamp Research that was successfully spun off from Global Integrity in 2013. Prior to co-founding Global Integrity, Nathaniel served at the US Department of State focusing on European political-military affairs; as a fellow at the Center for Public Integrity reporting on public sector accountability and ethics issues; and as a foreign policy fellow to the late-Senator Edward Kennedy.
Regan Hofmann is an internationally recognized authority on HIV/AIDS, Ms. Hofmann is the policy officer in UNAIDS’s U.S. Liaison Office in Washington, D.C., where she works to build stronger, more strategic collaborations with the Executive Branch of the U.S. government and the U.S. Congress to support the global response to AIDS. She also works with civil society and advocacy groups to build support for key UNAIDS priorities. Hofmann is an awarding-winning journalist who was formerly the editor in chief of POZ and poz.com, the leading media brand focused on HIV/ AIDS in the United States. She is an ambassador for the Elizabeth Glaser Pediatric AIDS Foundation and serves on God’s Love We Deliver’s Chairman’s Council. She was a U.S. delegate at the United Nations General Assembly’s Special Session on HIV/AIDS under both President George W. Bush and President Barack Obama and has traveled internationally on behalf of the U.S. Department of State to speak about reducing HIV/AIDS stigma. In 2009, the U.S. Secretary of Health and Human Services appointed Ms. Hofmann to the CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment. An openly HIV-positive woman whose memoir, I Have Something to Tell You, was published in 2009 by Simon and Schuster, Ms. Hofmann is an articulate and persuasive advocate. She has given testimony at Congressional briefings and has spoken numerous times at White House events focused on HIV/AIDS. Internationally, she has spoken at conferences, government and educational institutions, and AIDS fundraisers. Leveraging her background in publishing, TV media, and advertising, Ms. Hofmann has helped increase the visibility of the AIDS pandemic. She has appeared on CNN, NPR, NBC, The Doctors, C-SPAN, The Oprah Winfrey Show, ABC’s Good Morning America, and other media outlets, and has been featured in several national HIV/AIDS awareness and advertising campaigns. Ms. Hofmann has a B.A. from Trinity College in Connecticut.
Joan Holloway, is a Senior Advisor and Steering Committee Member at Frontline Health Workers Coalition (FHWC) and a Human Resources for Health (HRH) Consultant. As a consultant, she supports the work of UNAIDS, the HRSA Nursing Capacity Building Programs and Intrahealth’s CapacityPlus Project. Ms. Holloway served as a Commissioned Officer in the U.S. Public Health Service for over 30 years, retiring in 2000. During that time, she had led various bureaus at the U.S. Department of Health and Human Services (HHS), including the HIV/AIDS Bureau, the Bureau of Primary Health Care, the Bureau of Health Care Delivery and Assistance and the Bureau of Medical Services. From 2005 to 2010, Ms. Holloway was a Senior Adviser at the Office of the U.S. Global AIDS Coordinator (OGAC) of the U.S Department of State. She then served as Vice President of Global Health Initiatives at the International Association of Providers of AIDS Care (IAPAC) from 2010 to 2013.
Michael Alan Horberg, MD, MAS, FACP is Executive Director Research and Community Benefit of Mid-Atlantic Permanente Medical Group (MAPMG) and the director of the Mid-Atlantic Permanente Research Institute (MAPRI). He is also director of HIV/AIDS for Kaiser Permanente. Dr. Horberg has been appointed to serve on the Presidential Advisory Council on HIV/AIDS (PACHA), and co-chairs the Access to Care and Improved Outcomes Committee of PACHA. Dr. Horberg is a Fellow of the American College of Physicians, and he presently serves as Vice-Chair of the Board of Directors of the HIV Medicine Association of the Infectious Disease Society of America. He has co-chaired the NCQA/AMA/HRSA/IDSA sponsored Expert Panel on HIV-related provider performance measures. He is Assistant Clinical Professor at Stanford University Medical School. Dr. Horberg is past-president of the national Gay and Lesbian Medical Association. His HIV research interests are health service outcomes for HIV-infected patients (including HIV quality measures and care improvement, and determinants of optimized multidisciplinary care for maximized HIV outcomes), medication adherence issues in these patients, and epidemiology of the disease.
Jennifer Kates, PhD is Vice President and Director of Global Health & HIV Policy at the Kaiser Family Foundation. She oversees the Foundation’s policy analysis and research focused on the U.S. government’s role in global health and on the global and domestic HIV epidemics. Widely regarded as an expert in the field, she regularly publishes and presents on global health and HIV policy issues and is particularly known for her work analyzing donor government investments in global health; assessing and mapping the U.S. government’s global health architecture, programs, and funding; and tracking and analyzing major U.S. HIV programs and financing, and key trends in the HIV epidemic, an area she has been working in for twenty-five years. Prior to joining the Foundation in 1998, Dr. Kates was a Senior Associate with The Lewin Group, a health care consulting firm, where she focused on HIV policy, strategic planning/health systems analysis, and health care for vulnerable populations. Prior to that, she directed the Office of Lesbian, Gay, and Bisexual Concerns at Princeton University.
Rebecca Katz, PhD, MPH is an Associate Professor of Health Policy and Emergency Medicine at The George Washington University School of Public Health and Health Services. Her research is focused on public health preparedness, global health diplomacy, biosurveillance, and the intersection of infectious diseases and national security. Current research projects are focused on implementation of the International Health Regulations (2005). She also works on issues related to foodborne illness surveillance and response, and biosecurity and biosafety. Since 2004, Dr. Katz has been a consultant to the U.S. Department of State, working on issues related to the Biological Weapons Convention and emerging and pandemic threats.
Kevin A. Klock, JD is Head of Governance and Assistant Secretary for the GAVI Alliance, and Company Secretary for the GAVI Campaign. GAVI’s mission is to save children’s lives and protect people’s health by increasing access to immunization in poor countries. He advises on public sector and corporate governance best practice, particularly matters that concern board composition, evaluation, dynamics, and operations. In addition, he is the lead staff member on governance for matters that involve GAVI’s finance and debt-issuance activities including the International Finance Facility for Immunisation (IFFIm). He was previously with the National Association of Corporate Directors (NACD), which provides information, research, and education to corporate boards. He is a member of the Corporate Practices Committee of the Society of Corporate Secretaries and Governance Professionals and has served as a director on two boards. His comments have appeared in many industry publications including Corporate Board Member and Chief Executive.
John Kraemer, MPH, JD is an assistant professor in the Department of Health Systems Administration. Trained in both public health and the law, John is affiliated with the O’Neill Institute for National and Global Health Law at Georgetown University, where his work focuses primarily on women’s and children’s health in sub-Saharan Africa. He also conducts scholarship on public health law and ethics, with a particular focus on the ethical and legal limits of governmental action to address health concerns. Finally, he has an interest in road safety for vulnerable road users in both low-income settings and Washington, DC. His current and past projects have been with the George W. Bush Institute, the United Nations Special Envoy for Malaria, and the District of Columbia government. John is also an adjunct professor at Georgetown Law, and he works with the monitoring and evaluation team at Tiyatien Health, a non-profit providing clinical and community-based services in rural Liberia. At Georgetown, John teaches graduate epidemiology, both at the School of Nursing and Health Studies and at the law school, and undergraduate health disparities, health law and ethics, and global health law.
Katherine Leach-Kemon, MPH is a Policy Translation Specialist who works to ensure the Institute for Health Metrics and Evaluation’s (IHME) work is understood and used to inform policy debates. She writes and oversees the production of reports, infographics, and policy briefs, contributes to media outreach, and fosters and manages collaborations with external organizations. Katherine specializes in two of IHME’s research areas, Global Burden of Disease and health financing. Katherine originally worked at IHME as a Post-Graduate Fellow and was involved in the Institute’s production of the first Financing Global Health report. She continues to participatein this research in her current role. Katherine also served as a Peace Corps volunteer in Niger and received her MPH from the University of Washington.
Jong-Koo Lee, MD, MPH, PhD Seoul National University College of Medicine
Jeffrey Levi, PhD is Executive Director of the Trust for America’s Health, where he leads the organization’s advocacy efforts on behalf of a modernized public health system. He oversees TFAH’s work on a range of public health policy issues, including implementation of the public health provisions of the Affordable Care Act and annual reports assessing the nation’s public health preparedness, investment in public health infrastructure, and response to chronic diseases such as obesity. In January 2011, President Obama appointed Dr. Levi to serve as a member of the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. In April 2011, Surgeon General Benjamin appointed him chair of the Advisory Group. Dr. Levi is also Professor of Health Policy at the Milken Institute School of Public Health at the George Washington University, where his research has focused on HIV/AIDS, Medicaid, and integrating public health with the healthcare delivery system. He has also served as an associate editor of the American Journal of Public Health, Deputy Director of the White House Office of National AIDS Policy. Dr. Levi received a BA from Oberlin College, an MA from Cornell University, and a PhD from The George Washington University.
Daniel R. Lucey, MD is a Senior Scholar with the O’Neill Institute for National and Global Health Law. Dr. Lucey is an adjunct professor of microbiology and immunology at Georgetown University Medical Center (GUMC). A physician trained in infectious diseases and public health, he has taught for 11 years at Georgetown on global emerging infectious diseases. He completed his infectious disease training and MPH at Harvard and worked in the US Public Health Service at the National Institutes of Health. His infectious disease training and MPH were at Harvard 1985-1988, after medical residency at UCSF, and medical school and college at Dartmouth. After working at the NIH and Washington Hospital Center until 2002, he co-founded a graduate program on emerging infectious diseases and biohazardous threat agents at GUMC. He has traveled widely in Asia, Africa, and the Middle East to exchange information regarding infectious diseases such as SARS, influenza, Nipah, HIV, anthrax, and MERS. Dr. Lucey is an author on over 100 papers and book chapters.
Nicole Mahoney, PhD is the Director of Government Affairs & Regulatory Policy at Cubist, a wholly owned subsidiary of Merck, where she focuses on U.S. and international regulatory policy, with a particular emphasis on antibiotics and resistance. She works with a variety of stakeholders to spur antibiotic development and represents Cubist on the Innovative Medicines Initiative DRIVE AB Project, a joint undertaking by the EU and European Pharmaceutical Industry Association. Prior to joining Cubist, Nicole served as the senior officer for the Pew Charitable Trusts’ antibiotics and innovation project. She also served as a U.S. Food and Drug Administration Commissioner’s Fellow in the FDA’s Office of Antimicrobial Products, analyzing trends in the regulatory process for all new antibiotics reviewed by the agency over three decades. Nicole earned her PhD in biochemistry from the Albert Einstein College of Medicine and completed postdoctoral training at the University of California, San Francisco.
Mary Anne Marovich, MD is the Director of the Vaccine Research Program (VRP) at the National Institute of Allergy and Infectious Diseases (NIAID), where she leads the development and coordination of clinical and preclinical research on HIV vaccines. She came to NIH from the U.S. Military HIV Research Program (MHRP), where she served as chief of vaccine research and development since 2005. Additionally, Marovich worked as the clinic director for MHRP’s Rockville Vaccine Assessment Center, where she led multiple early-stage HIV and non-HIV vaccine clinical trials. She earned bachelor’s degrees in biochemistry and chemistry at Illinois State University and a medical degree at Loyola University of Chicago-Maywood. In 1993, she completed a residency in internal medicine and clinical infectious diseases training at the University of Colorado and earned a diploma in tropical medicine and hygiene from the Royal College of Physicians and Surgeons, London School of Tropical Medicine and Hygiene. An associate professor of medicine with the Uniformed Services University’s department of medicine, Marovich has won several honors for academic and teaching excellence.
Robert Marten, MPH, MPP joined The Rockefeller Foundation in 2010. Mr. Marten manages relationships with current and prospective grantees throughout the grantmaking process, coordinates Foundation work with partners, and conducts research in support of the strategic development and execution of Foundation initiatives. He works on the Transforming Health Systems (THS) initiative. Prior to joining The Rockefeller Foundation, Mr. Marten worked as a consultant with the World Bank, the World Health Organization, and German Technical Cooperation in Zambia and South Africa. He also worked as a researcher at the Global Public Policy Institute in Germany and served as a United Nations Volunteer on HIV/AIDS in Vietnam. Mr. Marten has published articles in the Lancet, Public Health, and the WHO Bulletin. He serves on the Board of Directors of the Global Health Council, is a member of the Advisory Council of the Young Professionals Chronic Disease Network, and is member of the editorial board of Global Health Governance. Mr. Marten received a bachelor’s degree from McGill University, a master’s degree in public policy from the Hertie School of Governance, a certificate in global health effectiveness from the Harvard School of Public Health, a master’s degree in public health from Johns Hopkins University, and is currently pursuing a doctoral degree from the London School of Hygiene and Tropical Medicine.
Ron MacInnis, has 25 years of experience promoting the development of community and civil society leadership and engagement with counterparts throughout Africa, Asia, and Latin America to successfully develop, adopt, and implement HIV policies and provide high-quality services. He is skilled at navigating public, private, NGO, and FBO sectors on HIV and RH issues; and augmenting local capacity to collect, analyze, disseminate, and use data for decision making and strategic planning. As Deputy Director for the global HIV portfolio of the PEPFAR/USAID-funded Health Policy Project at Futures Group, he contributed to building numerous national AIDS strategies, civil society action strategies, and coalition building among PLHIV and service provider networks and convened diverse groups of actors to advance evidence-based policies into practice on HIV treatment, HIV stigma, and removing legal barriers. Directing a team of health economists, sociologists, public health policy and program specialists and other stakeholders around the globe, he has stimulated research agendas across all areas of HIV evidence gathering. Specific support to key populations has included program design for MSM services in African countries and the Caribbean, for PWID in Eastern Europe and Central Asia, and transgendered Previously, he worked in USAID Office of HIV/AIDS as senior health policy advisor, as Director of Policy for the International AIDS Society in Geneva, Director of the Global AIDS Program of the Global Health Council, and served as a Peace Corps Volunteer in the Democratic Republic of the Congo.
Veronica Miller, PhD is the Executive Director of the Forum for Collaborative HIV Research (the Forum), a public/private partnership addressing cutting edge science and policy issues through a process of stakeholder engagement and deliberation. Dr. Miller has extensive experience in working with all major global and U.S. organizations and agencies involved in HIV research and policy. She is a leading expert in the process of engaging stakeholders from both sides of the Atlantic to resolve significant health policy and public health issues. Under her leadership the Forum’s deliberative process to advance regulatory science applied successfully to HIV was extended to drug development for hepatitis C infection in 2007, and starting in 2014, to the treatment of liver diseases (NASH and fibrosis), and human cytomegalovirus disease in solid organ and stem cell transplant patients. Efforts led by Dr. Miller to advance public health policy through stakeholder engagement include the National Summit program, which focuses on the implementation of the National HIV/AIDS Strategy and the Viral Hepatitis Action Plan; and the Bay Area Health Disparities Program.
Ya Diul Mukadi, MD, MPH is the Senior Tuberculosis Medical Advisor in the Office of Health Infectious Diseases, and Nutrition at USAID. In that role, he provides technical assistance to USAID country level TB programs, with a particular focus on Africa. Mukadi also provides senior level strategic and programming guidance and assists USAID missions in strengthening coordination and leveraging of USAID TB funds with President’s Emergency Plan for AIDS Relief resources. In addition, Mukadi provides technical support to the HIDN Infectious Diseases TB program. Prior to his fellowship, Mukadi was Chief of Party, Community Health and AIDS Mitigation Project. Prior to that he was Director of the Care and Treatment Division, Family Health International. He holds an MPH, Epidemiology from the University of Washington and an MD in Surgery and Delivery from the University of Kinshasa.
Subarna Mukherjee, MPH, MSN Frontline Health Systems Director at Last Mile Health
Saad Omer, MBBS, MPH, PhD is an Associate Professor of Global Health, Epidemiology, & Pediatrics at Emory University, Schools of Public Health and Medicine. He is also a faculty member at the Emory Vaccine Center. He has conducted multiple studies – including vaccine trials – in Guatemala, Uganda, Ethiopia, India, Pakistan, Bangladesh, South Africa, and the United States. Dr. Omer’s research portfolio includes clinical and field trials to estimate efficacy and/or immunogenicity of influenza, polio, measles and pneumococcal vaccines; studies on the impact of spatial clustering of vaccine refusers; and clinical trials to evaluate drug regimens to reduce mother-to-child transmission of HIV in Africa. He has conducted several studies to evaluate the roles of schools, parents, health care providers, and state-level legislation in relation to immunization coverage and disease incidence. Dr. Omer has published widely in peer reviewed journals including the New England Journal of Medicine, JAMA, the Lancet, British Medical Journal, Pediatrics, American Journal of Public Health, and American Journal of Epidemiology. In 2009, Dr Omer was awarded the Maurice Hilleman award in vaccinology by the National Foundation of Infectious Diseases on his work on impact of maternal influenza immunization on respiratory illness in infants younger than 6 months- for whom there is no vaccine.
Matthew Penn, JD, MLIS is the director of the Public Health Law Program within CDC’s Office for State, Tribal, Local and Territorial Support. He provides critical legal expertise and leadership to advance public health practice through law. In this role, Penn leads a team of public health advisors and analysts in supporting practitioners and policy makers at the state, tribal, local, and territorial levels through the development of practical, law-centered tools and legal preparedness to address public health priorities. Prior to joining CDC, Penn served 9 years as a staff attorney for the South Carolina Department of Health and Environmental Control. In this position he provided in-house counsel and litigation services on legal issues in the areas of health services delivery, public health law, HIPAA, environmental health, disease control, public health and bioterrorism preparedness, and health regulation.
Joy Pritts, JD is a Health Information Privacy and Security Consultant with over 15 years expertise in health information privacy. She has deep expertise in federal and state laws governing the collection, use and disclosure of health information. She served as the first Chief Privacy Officer, Office of the National Coordinator for Health Information Technology, US Dept. of Health and Human Services from 2010 until July 2014. In that capacity, she provided critical advice to the Secretary of HHS and the National Coordinator on health information privacy and security policies, with the goal of ensuring that the policies kept pace with the evolving technology. Prior to her government service, Pritts held a joint position at Georgetown University’s Health Policy Institute and O’Neil Institute for National and Global Health Law. Her research helped inform the privacy and security standards developed under the Health Insurance Portability and Accountability Act, the Fair and Accurate Credit Transactions Act, the Gramm-Leach-Bliley Act, and the Genetic Information Nondiscrimination Act. She currently provides consulting advice to clients in the health IT sector on emerging privacy and security issues.
Jason Sigurdson recently joined the UNAIDS U.S. Liaison Office as Senior Policy and Strategy Adviser, and was previously a Human Rights and Law Adviser with UNAIDS in Geneva. He has a joint honours in sociology and political science from McGill University (Montreal, Canada), and in 2004 received a Master of Public Administration and Bachelor of Laws (MPA/LL.B.) from Dalhousie University (Halifax, Canada). Prior to joining UNAIDS in 2005, Jason was a research assistant with the Office of the United Nations High Commissioner for Human Rights, focusing on the rights to adequate housing and the highest attainable standard of health. He earlier served as an Ethics Fellow with the World Health Organization, supporting work on equitable access to HIV treatment and care within the “3 by 5 Initiative” (provide HIV treatment to 3 million people living with HIV by the end of 2005).
Paolo Sison, MBA, MSc is the Director of Innovative Finance at GAVI Alliance, a public-private global health partnership committed to saving lives and protecting people’s health by increasing access to immunisation in poor countries. GAVI is a leading force in innovative finance for development, having developed the International Finance Facility for Immunisation, the Pneumococcal Advance Market Commitment and recently the GAVI Matching Fund. Before joining GAVI, Sison spent ten years in investment banking in London, most recently as director, Global Banking and Markets at HSBC, where he was responsible for equity and equity-linked origination in the financial services sector across Western Europe and CEEMEA. His markets experience includes fixed income, hybrid products and derivative structuring. Previously, he spent six years in Manila and in Tokyo, with Ayala Corporation’s Strategic Planning Group and with Mitsubishi Corporation’s Development & Coordination Department. During this time he looked after the business groups’ investments in the financial services and industrial sectors, and was actively involved in business development in the Asia-Pacific region. Sison holds an MSc in Finance from London Business School, an MBA from the Asian Institute of Management and an AB Theology (magna cum laude) from the Asian Seminary of Christian Ministries.
John Ward, MD is Director of the Division of Viral Hepatitis at NCHHSTP, CDC. Ward is respon-sible for planning and directing national and international research, surveillance and public health programs related to viral hepatitis prevention and control.In addition to his work in viral hepatitis, Ward’s experience includes 14 years in the field of HIV/AIDS conducting early studies of AIDS transmission, natural history and diagnosis, evaluat-ing prevention measures to protect the blood supply and directing national HIV/AIDS surveil-lance. Ward has also served as Editor of the Morbidity and Mortality Weekly Report (MMWR), CDC’s primary health publication. As Editor, Ward created the Epidemic Information Exchange (Epi-X), a secure, moderated system for public health officials to report and discuss disease outbreaks and other health events. Ward has authored over 100 scientific publications and recently served as Editor for Silent Victories, a history of public health in the 20th century published in 2007 by Oxford University Press. Ward received his medical degree from the University of Alabama School of Medicine in Birmingham and completed an internship and residency in internal medicine at the University of Alabama Hospitals with additional postgraduate training at the London School of Tropical Medicine and Hygiene, CDC’s Epidemic Intelligence Service and the infectious diseases fellowship program at the University of Washington Medical Center in Seattle. He holds a clinical faculty appointment with the Department of Medicine, Emory University.
Sherrie Flynt Wallington, PhD is Assistant Professor of Oncology and serves as the program director for the Health Disparities Initiative. Her research interests focus on using community-based and community-based participatory research approaches to explore the role of health communication in reducing and eliminating health disparities among minority and underserved populations. Dr. Wallington recently completed a postdoctoral fellowship with the Harvard School of Public Health and the Dana Farber Cancer Institute. Dr. Wallington attended Howard University and received a Ph.D. in mass communication, specializing in health communication and also holds undergraduate and graduate degrees from the University of North Carolina at Greensboro.
Lindsay F. Wiley, AB, JD, MPH teaches torts, health law, and public health law. Her research focuses on access to health care and healthy living conditions in the U.S. and globally. She serves on the Board of Directors of the American Society for Law, Medicine, and Ethics and the National Conference of Lawyers and Scientists. Prior to joining the faculty at WCL, Professor Wiley was the Global Health Law Program Director at the O’Neill Institute for National and Global Health Law at Georgetown University. She had also previously worked at the Center for Law and the Public’s Health at the Johns Hopkins Bloomberg School of Public Health, the American Society for Law, Medicine, and Ethics, and Gordon, Feinblatt, Rothman LLC in Baltimore, MD. She received her AB and JD from Harvard, where she served on the Harvard Law Review, and her MPH from Johns Hopkins.